Format

Send to

Choose Destination
Korean J Pediatr. 2019 May 31. doi: 10.3345/kjp.2019.00227. [Epub ahead of print]

Recommended Immunization Schedule for Children and Adolescents: Committee on Infectious Diseases of the Korean Pediatric Society, 2018.

Author information

1
Department of Pediatrics, College of Medicine, Yonsei University, Seoul, Korea.
2
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
3
Department of Pediatrics, School of Medicine, Pusan National University, Pusan, Korea.
4
Department of Pediatrics, Sungkyunkwan University School of Medicine, Suwon, Korea.
5
Department of Pediatrics, Chonbuk National University Medical School, Jeonju, Korea.
6
Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.
7
Department of Pediatrics, School of Medicine, Eulji University, Daejeon, Korea.
8
Department of Pediatrics, CHA University School of Medicine, Pocheon, Korea.
9
Department of Pediatrics, University of Ulsan College of Medicine, Ulsan, Korea.
10
Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
11
Department of Pediatrics, Gachon University College of Medicine, Incheon, Korea.

Abstract

The Committee on Infectious Diseases of the Korean Pediatric Society (KPS) recommended immunization schedule for children and adolescents aged 18 years or younger in the 9th (2018) edition of Immunization Guideline. This report provides the revised recommendations made by the committee and summarizes several changes from the 2015 guideline. National immunization program (NIP) launched a human papillomavirus (HPV) immunization for girls aged 12 years in 2016. NIP has also expanded age indication for inactivated influenza vaccine (IIV) to 12 years of age in the 2018-2019 season. Quadrivalent IIVs with a full dose (0.5 mL) are approved for all children of 6 months or older. Recommendations of live attenuated influenza vaccine were removed. For inactivated Japanese encephalitis vaccine (JEV), first two doses are considered as the primary series. Recommendations for use of newly introduced vaccines (diphtheria-tetanus-acellular pertussis/inactivated poliovirus/Haemophilus influenzae type b, 9-valent HPV, new varicella vaccine, new quadrivalent IIV, and attenuated oral typhoid vaccine) were added. Lastly, monitoring system for adverse events following immunization was updated. Other changes can be found in the 9th edition of Immunization Guideline in detail.

KEYWORDS:

Adolescent; Child; Immunization schedule; Infant; Korea

PMID:
31163961
DOI:
10.3345/kjp.2019.00227
Free full text

Supplemental Content

Full text links

Icon for Publishing M2Community
Loading ...
Support Center